Toward the 1,000 dollars human genome
- PMID: 16004555
- DOI: 10.1517/14622416.6.4.373
Toward the 1,000 dollars human genome
Abstract
Revolutionary new technologies, capable of transforming the economics of sequencing, are providing an unparalleled opportunity to analyze human genetic variation comprehensively at the whole-genome level within a realistic timeframe and at affordable costs. Current estimates suggest that it would cost somewhere in the region of 30 million US dollars to sequence an entire human genome using Sanger-based sequencing, and on one machine it would take about 60 years. Solexa is widely regarded as a company with the necessary disruptive technology to be the first to achieve the ultimate goal of the so-called 1,000 dollars human genome - the conceptual cost-point needed for routine analysis of individual genomes. Solexa's technology is based on completely novel sequencing chemistry capable of sequencing billions of individual DNA molecules simultaneously, a base at a time, to enable highly accurate, low cost analysis of an entire human genome in a single experiment. When applied over a large enough genomic region, these new approaches to resequencing will enable the simultaneous detection and typing of known, as well as unknown, polymorphisms, and will also offer information about patterns of linkage disequilibrium in the population being studied. Technological progress, leading to the advent of single-molecule-based approaches, is beginning to dramatically drive down costs and increase throughput to unprecedented levels, each being several orders of magnitude better than that which is currently available. A new sequencing paradigm based on single molecules will be faster, cheaper and more sensitive, and will permit routine analysis at the whole-genome level.
Similar articles
-
Advances in sequencing technology.Mutat Res. 2005 Jun 3;573(1-2):13-40. doi: 10.1016/j.mrfmmm.2005.01.004. Mutat Res. 2005. PMID: 15829235 Review.
-
Solexa Ltd.Pharmacogenomics. 2004 Jun;5(4):433-8. doi: 10.1517/14622416.5.4.433. Pharmacogenomics. 2004. PMID: 15165179
-
Helicos BioSciences.Pharmacogenomics. 2008 Apr;9(4):477-80. doi: 10.2217/14622416.9.4.477. Pharmacogenomics. 2008. PMID: 18384261 Review.
-
Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays.Science. 2010 Jan 1;327(5961):78-81. doi: 10.1126/science.1181498. Epub 2009 Nov 5. Science. 2010. PMID: 19892942
-
How next-generation sequencing is transforming complex disease genetics.Trends Genet. 2013 Jan;29(1):23-30. doi: 10.1016/j.tig.2012.10.001. Epub 2012 Oct 25. Trends Genet. 2013. PMID: 23103023 Review.
Cited by
-
Sequencing by ligation variation with endonuclease V digestion and deoxyinosine-containing query oligonucleotides.BMC Genomics. 2011 Dec 12;12:598. doi: 10.1186/1471-2164-12-598. BMC Genomics. 2011. PMID: 22151854 Free PMC article.
-
Connector inversion probe technology: a powerful one-primer multiplex DNA amplification system for numerous scientific applications.PLoS One. 2007 Sep 19;2(9):e915. doi: 10.1371/journal.pone.0000915. PLoS One. 2007. PMID: 17878950 Free PMC article.
-
Challenges and standards in integrating surveys of structural variation.Nat Genet. 2007 Jul;39(7 Suppl):S7-15. doi: 10.1038/ng2093. Nat Genet. 2007. PMID: 17597783 Free PMC article. Review.
-
Magnetic biosensor technologies for medical applications: a review.Med Biol Eng Comput. 2010 Oct;48(10):977-98. doi: 10.1007/s11517-010-0649-3. Epub 2010 Jun 24. Med Biol Eng Comput. 2010. PMID: 20574723 Review.
-
Comparative sequencing of plant genomes: choices to make.Plant Cell. 2006 May;18(5):1100-4. doi: 10.1105/tpc.106.042192. Plant Cell. 2006. PMID: 16670439 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources